New Trends in the DeSci Track: The Compound Project EGS Ignites the Market, Can It Revitalize Industry Enthusiasm?

robot
Abstract generation in progress

The DeSci track stirs up waves again, the new compound project draws attention

The decentralized science (DeSci) sector has recently seen new developments. A well-known project is about to launch a new launch platform, attracting market attention. The prices of the project's two tokens subsequently rose by about 20%. Previously, the project's co-founder stated plans to launch 20 new compound tokens by Christmas 2024.

However, this plan has been postponed to this day. Over the past three months, due to external factors, the market value of the two official tokens of the project has dropped more than 95% from their peak. During the same period, another DeSci financial project also fell about 90% after being listed on a certain exchange. The DeSci track, which was once favored by several well-known industry figures, seems to be in trouble.

Is DeSci over? Is the Pump.Science new compound project worth participating in?

Can the new launch platform revive DeSci?

According to the official documentation, the operational process of the new launch platform is as follows:

  • Users can list compounds and their corresponding tokens on the platform.
  • Users can buy and sell tokens through bonding curves to support compound research.
  • 79% of the tokens are issued through bonding curves.
  • The market cap of the token reached 303 Sol with ( circulating 85 Sol ), bonding curve closed.
  • 82 Sol liquidity transferred to Meteora exchange
  • 3 Sol for experimental fees

It is worth noting that the new platform will adopt a dynamic fee structure to prevent sniper bots:

  • The first 150 blocks ( takes about 2 minutes ) charges extremely high fees ( 99.99% )
  • The fees between blocks 150-250 have decreased rapidly.
  • Aimed at reducing early frontrunning behavior

The white paper also mentions that all new compounds must airdrop a certain share to the holders of the original two tokens. This is clearly an attempt by the project party to save itself. The weak DeSci track urgently needs new hotspots and wealth creation effects. Currently, various projects are emerging one after another in the market. Can DeSci attract attention again and bring in incremental growth? This is undoubtedly a key moment that will determine the future direction of DeSci.

The new compound project EGS has sparked heated discussions.

Recently, a new compound project called EGS has attracted widespread attention. The project completed its pre-sale within 24 hours, raising 1223 Sol. Subsequently, the project team announced that they would refund 91.87% of the raised funds, keeping only 100 Sol for launch and liquidity support. This "high raise high refund" strategy is similar to that of a previous popular project, but the refund rate has set a new high for DeSci projects.

EGS is composed of two compounds: Epigallocatechin Gallate ( EGCG ) and sulforaphane. EGCG is an antioxidant component in green tea that can activate the AMPK pathway to inhibit cellular aging. Studies have shown that it can extend the lifespan of certain organisms by up to 20%. Sulforaphane enhances cellular antioxidant capacity by activating the Nrf2 pathway, with experiments confirming it can extend the lifespan of mice by approximately 15%. Both are natural longevity candidate molecules with clinical translation potential.

The EGS project adopts an innovative presale model, combining DeSci's scientific narrative. Whether it can achieve success on the new platform remains to be seen. The project's co-founder admitted that DeSci faces the contradiction between narrative and implementation, and how to balance the needs of users supporting science and generating profits is key.

In the current market environment, a singular decentralized scientific narrative is difficult to attract sufficient follow. The revival of the DeSci track still has a long way to go and requires more innovative approaches to attract investors. We hope this new compound project can bring new vitality to DeSci, while also rewarding those steadfast supporters.

Other new compounds coming soon

In addition to EGS, there are several new compound projects set to launch, including:

  1. Pomegranate polyphenols and berberine
  2. Resveratrol and Berberine
  3. Ginsenoside Rh2
  4. Aspartame and Caffeine
  5. Cotton phenol and catechin hydrate
  6. Biotin and Berberine
  7. Urolithin A and EGCG
  8. Berberine and Quercetin
  9. Hesperidin and Dihydromyricetin
  10. EGCG
  11. Caffeine
  12. Artemisinin

These compounds each have distinct characteristics, involving multiple aspects such as antioxidant, metabolic regulation, and neuroprotection. Recently, with a certain research institution reaffirming the DeSci track, related tokens have seen a certain increase. New compound projects are set to be launched one after another, and investors need to continue to follow and identify high-quality projects among them.

EGS0.3%
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • 6
  • Repost
  • Share
Comment
0/400
SingleForYearsvip
· 15h ago
Another field of suckers.
View OriginalReply0
BearMarketSurvivorvip
· 22h ago
If you make a lot of money, you have to run.
View OriginalReply0
FloorSweepervip
· 08-12 20:09
Science can also be speculated.
View OriginalReply0
AirdropLickervip
· 08-12 20:08
Just continue trading tokens.
View OriginalReply0
EthSandwichHerovip
· 08-12 20:06
Another field of suckers.
View OriginalReply0
CryptoMotivatorvip
· 08-12 19:57
Technology did not meet expectations.
View OriginalReply0
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate app
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)